Budesonide Azure 0.5 mg / 2 ml Nebuliser Suspension

Licence status
Authorised: 06/02/2026
Active substances
Budesonide
Dosage Form
Nebuliser suspension
Licence number
PA22871/035/001
Licence holder
Azure Pharmaceuticals Ltd.

Product documents

Licence information

ATC code
R03BA02 budesonide
Legal supply status
Product subject to prescription which may be renewed (B)
Place of sale
Supply through pharmacies only
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
06/02/2026